Pentafulvene-Maleimide Cycloaddition for Bioorthogonal Ligation

Area of Science:

• Chemical Biology
• Organic Chemistry
• Bioconjugation Chemistry

Background:

• Bioconjugation chemistry is crucial for advancing biological and medical sciences.
• New bioconjugation strategies are needed to expand the field's capabilities.

Purpose of the Study:

• To investigate the Diels-Alder cycloaddition (DAC) reaction between pentafulvenes and maleimides as a novel bioconjugation strategy.
• To evaluate the reaction's efficiency, bioorthogonality, and utility in biological applications.

Main Methods:

• Studied DAC reactions between pentafulvenes and maleimides in aqueous solutions.
• Assessed reaction rates and yields for various maleimides, including peptide and protein conjugates.
• Evaluated the bioorthogonality by testing cross-reactivity with biomolecules and biological media.

Main Results:

• DAC reactions proceeded efficiently and quantitatively, yielding cycloadducts with high reaction rates (up to ~0.7 M⁻¹ s⁻¹).
• Pentafulvenes showed no cross-reactivity with a wide range of functional (bio)molecules and biological media, confirming bioorthogonality.
• Demonstrated utility in protein derivatization and labeling in biological settings, achieving results comparable to sulfhydryl-maleimide chemistry.

Conclusions:

• The DAC reaction between pentafulvenes and maleimides is a promising, bioorthogonal bioconjugation strategy.
• This method offers high efficiency, selectivity, and broad applicability in biological systems.
• It represents a valuable addition to the bioconjugation toolbox for future research and development.